Accenture and Ajinomoto team-up to form a new joint venture in Japan
By Akshay Kedari  Date: 2019-12-09

Accenture and Ajinomoto team-up to form a new joint venture in Japan

Accenture, an Irish-domiciled multinational professional services company, and Ajinomoto Co., Inc, a Japan based food and biotechnology corporation, have reportedly signed a new agreement to establish a joint venture in Japan. The tie-up is to help Ajinomoto expedite its operational transformation.

The new firm, Ajinomoto Digital Business Partners Co., Inc., will now carry out the operations of Ajinomoto’s corporate divisions, including office management, procurement and human resources. The new company will be 33% owned by Accenture and 67% by Ajinomoto.

Ajinomoto Digital Business Partners would leverage the power of analytics, artificial intelligence and robotic process automation along with other solutions for business process transformation, to deliver services that further enhance the efficiency and functionality of Ajinomoto’s corporate functions, to help Ajinomoto drive substantial business value. Accenture will now leverage its proficiency in digital transformation in the field of business process services as well as consumer goods and services industry.

Masaya Tochio, representative director, senior corporate vice president and board member, Ajinomoto, reportedly stated that the tie-up will encourage the next gen of talent to provide competing services and help the company perform a turn towards an operating model that can consistently deliver greater customer values. Tochio further added, that the firm is focused on improving employee productivity and on priority product areas to realize sustainable growth and thus establish itself as a genuine global specialty company.

Atsushi Egawa, managing director of Accenture, Japan, stated that the company needs to include digital technologies in every process with cooperation from external partners, for organizations to drive change by enhancing productivity and creating new values.

Ajinomoto agreed to form JV partnership with Accenture to enhance its corporate capabilities and accelerate its operational transformation to a greater degree than the company could have done on its own. This JV would further enable Ajinomoto to achieve its vision of becoming a global specialty company driven by innovative bioscience and chemical technologies.

Source credit: https://newsroom.accenture.com/news/ajinomoto-and-accenture-to-establish-joint-venture-to-help-drive-ajinomotos-operational-transformation.htm

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

GVN adds EVIT Center and Chumakov as its new Centers of Excellence
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of th...

Wind Point Partners takes over RTIC to expand business portfolio
Wind Point Partners takes over RTIC to expand business portfolio
By Akshay Kedari

American private equity firm, Wind Point Partners has recently signed an acquisition deal with the one of the biggest direct-to-consumer (D2C) eCommerce providers of drinkware, RTIC. Reportedly, RTIC is Wind Point’s third acquisition of a famil...

Novartis reveals positive data from Phase III ORION trials of inclisiran
Novartis reveals positive data from Phase III ORION trials of inclisiran
By Akshay Kedari

Swiss multinational pharmaceutical firm, Novartis has recently announced results from its Phase III ORION-10 and -11 studies that focus on assessing the individual responses of patients on lowering low-density lipoprotein cholesterol (LDL-C) with inc...

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...